about
Tolvaptan: A Novel Diuretic in Heart Failure ManagementA novel therapeutic effect of statins on nephrogenic diabetes insipidusManagement of severe hyponatremia: infusion of hypertonic saline and desmopressin or infusion of vasopressin inhibitors?Clinical review: practical approach to hyponatraemia and hypernatraemia in critically ill patientsThe subcellular localization of an aquaporin-2 tetramer depends on the stoichiometry of phosphorylated and nonphosphorylated monomers.Osmotic stress signaling and osmoadaptation in yeasts.Lixivaptan - an evidence-based review of its clinical potential in the treatment of hyponatremia.GATA2 regulates body water homeostasis through maintaining aquaporin 2 expression in renal collecting ducts.Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy.cAMP regulated membrane diffusion of a green fluorescent protein-aquaporin 2 chimera.Evaluation of The Protective Effect of Hydro-Alcoholic Extract of Raspberry Fruit on Aquaporin1 Expression in Rats Kidney Treated by Methotrexate.Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters.Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study.Characterization of D150E and G196D aquaporin-2 mutations responsible for nephrogenic diabetes insipidus: importance of a mild phenotype.Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects.Characterization of the transcriptome, nucleotide sequence polymorphism, and natural selection in the desert adapted mouse Peromyscus eremicus.Antinatriuretic effect of vasopressin in humans is amiloride sensitive, thus ENaC dependent.Tolvaptan, hyponatremia, and heart failure.Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase.Age-related changes in expression in renal AQPs in response to congenital, partial, unilateral ureteral obstruction in rats.Pharmacokinetics and renal excretion of desmopressin after intravenous administration to healthy subjects and renally impaired patientsRapid Identification of Novel Inhibitors of the Human Aquaporin-1 Water Channel.Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjectsThe renal concentrating mechanism and the clinical consequences of its loss.Expression and localization of aquaporins in benign prostate hyperplasia and prostate cancerUrine concentration in the diabetic mouse requires both urea and water transportersThe phosphorylation state of serine 256 is dominant over that of serine 261 in the regulation of AQP2 trafficking in renal epithelial cells.Notch in the kidney: development and disease.Potential role of purinergic signaling in urinary concentration in inner medulla: insights from P2Y2 receptor gene knockout miceContribution of aquaporins to cellular water transport observed by a microfluidic cell volume sensorEstablished and newly proposed mechanisms of chronic cyclosporine nephropathyP2Y(2) receptors and water transport in the kidney.Dual modulation of urinary bladder activity and urine flow by prostanoid EP3 receptors in the conscious ratAquaporins: The renal water channels.Renal epithelial miR-205 expression correlates with disease severity in a mouse model of congenital obstructive nephropathy.Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.Effects of imidapril treatment on aquaporin-2 expression in the kidneys and excretion in the urine of hypertensive rats.V2 receptor antagonist; tolvaptanEffects of gonadectomy and testosterone treatment on aquaporin expression in the kidney of normotensive and hypertensive rats.Expression of brain-derived neurotrophic factor in kidneys from normal and cyclosporine-treated rats.
P2860
Q26741174-C8A0FAC2-A243-460D-8202-95B32B134396Q27005638-8B54CBB9-4526-4598-9F14-B781C2545F59Q27009510-9C6D8487-284D-4F92-AFDF-F8E394AB41E3Q27026378-C9473B09-7808-45DA-BC22-7E67D0DEDD53Q27876231-E2397700-DE64-4E0A-B09E-A7671EADB540Q29617597-4FAF475A-28CF-4689-8D4A-C6CDDF97451DQ30418165-7965B5FF-53B4-4B08-A0A5-CDDB66B84F04Q30424287-73B0A073-1688-48F6-9FD8-14BDDC4EAEDCQ30432267-278AD0BA-2430-4810-A358-CF0380EF2C10Q30835602-F067D42B-1A68-4314-875C-7DE158F16146Q33625820-8EB9BE24-ACA0-4E18-9A47-8B9A877395ECQ33632422-5E1BCCF3-8797-4FFA-9202-8D73D9F48BCBQ33712822-48AA6235-5DE6-432D-97C9-8832C1572EB6Q33793188-048ABA68-0518-4D69-AA90-372AB632C148Q33838160-14E02F86-9C36-4D01-983A-8D38CFFB0CA3Q34440981-E6516465-92CE-4E1B-A119-0185C43316A6Q34751826-72647AD7-4629-43B8-80DD-DEC3D6E6F05BQ35026759-6F6F211D-393B-4778-B84F-54CF786B1AE0Q35159559-F615DB5A-8F63-4F80-98DA-E92601483BA1Q35571809-5AD9DCC8-B00F-4321-ABEC-C9B71A3D75A0Q35826402-024979D4-B33B-4ED3-98B7-77D0F77544ADQ35873458-CF900FDC-CF55-46D9-9605-8AA75A1848E6Q36306545-F66328B8-93E5-42E5-8C31-39DDFBA6BB95Q36491051-EBA0D967-8575-4BA9-A4C6-F6D0B328C03FQ36514861-49A34D23-0FA2-4D16-9A6E-DE204406DA74Q36527875-76ED39EB-D644-45CC-9511-2F3163A75B70Q36807071-1D48D8D1-EDDF-4E38-B5FA-0F0A027247CAQ36914833-800D38EF-0C8A-4C99-A11A-5DAA3A151748Q37018451-C3E5F72C-FA65-4AFB-B804-B5B6AC7A5CCDQ37033715-EC0B21AD-B381-4060-8B53-D5F57BB5848CQ37232923-7B38D64E-F378-4844-955A-466122116961Q37418657-B76843FC-94A0-423C-B22B-583E9E1AF47FQ37481262-39AE323D-D0C7-459C-A6C6-D306EB37D28FQ40076699-1126442C-9E2B-4623-B3F1-17295557477EQ40989498-2A4EDEB1-9300-4ED3-A1A6-BB4967031A6EQ41431126-12163276-A9C6-479F-B286-C000AD08545FQ41484716-67635EE8-E641-4BB5-A436-9E2A1180FA34Q42583438-295D92CF-8AD5-4FB6-B62D-1BCF987C7F76Q47102931-D7F83802-8E5A-4817-95BC-CAE5C7919042Q52655696-B2FCAD6D-3E95-49B4-A66F-3D7E33E27BB7
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Physiology and pathophysiology of renal aquaporins.
@ast
Physiology and pathophysiology of renal aquaporins.
@en
Physiology and pathophysiology of renal aquaporins.
@nl
type
label
Physiology and pathophysiology of renal aquaporins.
@ast
Physiology and pathophysiology of renal aquaporins.
@en
Physiology and pathophysiology of renal aquaporins.
@nl
prefLabel
Physiology and pathophysiology of renal aquaporins.
@ast
Physiology and pathophysiology of renal aquaporins.
@en
Physiology and pathophysiology of renal aquaporins.
@nl
P2093
P1476
Physiology and pathophysiology of renal aquaporins
@en
P2093
P304
P577
1999-03-01T00:00:00Z